VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Boston Scientific Corporation vs DSM-Firmenich AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Boston Scientific Corporation
BSX · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.
View BSX analysisDSM-Firmenich AG
DSFIR · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into DSM-Firmenich AG's moat claims, evidence, and risks.
View DSFIR analysisComparison highlights
- Moat score gap: Boston Scientific Corporation leads (65 / 100 vs 63 / 100 for DSM-Firmenich AG).
- Segment focus: Boston Scientific Corporation has 5 segments (49.8% in Cardiology); DSM-Firmenich AG has 4 segments (31% in Perfumery & Beauty).
- Moat breadth: Boston Scientific Corporation has 6 moat types across 3 domains; DSM-Firmenich AG has 10 across 4.
Primary market context
Boston Scientific Corporation
Cardiology
Cardiology devices (interventional cardiology, structural heart, electrophysiology, cardiac rhythm management and remote monitoring)
Global
Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists)
Medical device OEM / implantables + procedure devices + service-enabled monitoring
49.8%
DSM-Firmenich AG
Perfumery & Beauty
B2B fragrances, perfumery ingredients, and beauty ingredients
Global
Consumer brands (fine fragrance, personal care, home care) and beauty brands
Ingredient supplier / fragrance house (co-creation + ingredient palette)
31%
Side-by-side metrics
Moat coverage
Shared moat types
Boston Scientific Corporation strengths
DSM-Firmenich AG strengths
Segment mix
Boston Scientific Corporation segments
Full profile >Endoscopy
Oligopoly
Urology
Competitive
Neuromodulation
Oligopoly
Cardiology
Oligopoly
Peripheral Interventions
Competitive
DSM-Firmenich AG segments
Full profile >Perfumery & Beauty
Oligopoly
Taste, Texture & Health
Oligopoly
Health, Nutrition & Care
Competitive
Animal Nutrition & Health
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.